Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,HR[95%CI],P_value
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",24216,887,1.62 [1.35-1.94],1.401265176235077e-07
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Candidiasis,24454,264,1.90 [1.45-2.49],3.896125796135572e-06
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,23755,2406,1.55 [1.37-1.74],3.1622798627830897e-13
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),23979,1817,1.50 [1.31-1.72],8.813412305308319e-09
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,23339,562,2.19 [1.78-2.69],1.497242324249069e-13
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,22547,530,2.23 [1.77-2.81],1.4831106919164225e-11
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Implicit fungal Sepsis,22776,150,2.71 [1.89-3.91],7.585094826288998e-08
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,18182,1060,1.54 [1.29-1.85],2.957386010022394e-06
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Mycoses,24512,322,1.83 [1.41-2.37],5.757908832997722e-06
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,23870,541,1.92 [1.57-2.34],2.4506588330116767e-10
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,24458,616,2.08 [1.70-2.55],1.956868382105926e-12
CLSTN3,Calsyntenin-3,Chapter I Certain infectious and parasitic diseases,Other septicaemia,24385,543,2.20 [1.78-2.71],1.595927510153364e-13
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,"Chronic lymphocytic leukaemia and small lyphocytis leukaemia, excluding all cancers (controls excluding all cancers)",21187,31,3.93 [2.56-6.05],4.0433375191514366e-10
CLSTN3,Calsyntenin-3,Chapter II Neoplasms,Lymphoid leukaemia,21184,28,3.36 [2.10-5.40],4.99703207068407e-07
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,23839,1961,1.53 [1.34-1.74],1.2270351559806856e-10
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,24156,891,1.57 [1.30-1.89],3.293416040619705e-06
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,24156,891,1.57 [1.30-1.89],3.293416040619705e-06
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,24306,803,1.60 [1.33-1.93],9.325808676509412e-07
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Purpura and other haemorrhagic conditions,24380,168,2.49 [1.90-3.27],3.473835301052433e-11
CLSTN3,Calsyntenin-3,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,"Thrombocytopenia, unspecified",24356,144,2.42 [1.79-3.28],1.1059813522501789e-08
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Acidosis,21072,180,2.90 [2.01-4.17],9.75787223401671e-09
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,23015,2123,1.45 [1.27-1.65],2.998629559207194e-08
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases","Disorders of plasma-protein metabolism, not elsewhere classified",20927,35,4.72 [2.84-7.85],2.290498394480833e-09
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Fluid overload,21003,111,3.28 [2.35-4.59],3.5362638171260232e-12
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,23930,3038,1.40 [1.26-1.57],1.250470069212852e-09
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",21685,793,2.01 [1.65-2.46],4.444193245689618e-12
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,22955,108,2.60 [1.82-3.73],1.8634358562660215e-07
CLSTN3,Calsyntenin-3,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,24188,1341,2.02 [1.76-2.31],1.6606709211216478e-23
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,17428,810,1.62 [1.32-1.99],3.213623986868841e-06
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,23902,1198,1.65 [1.40-1.94],1.890474226393981e-09
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,22811,5399,1.30 [1.19-1.41],5.24469586852615e-10
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Heart failure, strict",24446,461,1.90 [1.50-2.41],9.19310809783516e-08
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Hypertension,23319,4393,1.26 [1.15-1.38],4.390603468017545e-07
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Hypertension, essential",23327,4401,1.26 [1.15-1.38],6.588296683398549e-07
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Hypertension, portal",24397,48,4.07 [2.88-5.76],1.9873627106865195e-15
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",19007,81,2.58 [1.76-3.77],9.922313081299826e-07
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",24053,1339,1.52 [1.30-1.78],2.503996142993918e-07
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other other unspecified disorders of the circulatory system,23898,41,3.28 [2.24-4.80],1.0144248572325122e-09
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,24145,139,2.29 [1.63-3.22],1.5863751404034204e-06
CLSTN3,Calsyntenin-3,Chapter IX Diseases of the circulatory system,Secondary right heart disease,24142,136,2.30 [1.62-3.25],2.737271199967664e-06
CLSTN3,Calsyntenin-3,Chapter VI Diseases of the nervous system,Small fibre neuropathy,24320,31,3.44 [2.12-5.57],5.768337770908417e-07
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,22828,3787,1.27 [1.15-1.40],1.2520424420600077e-06
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Influenza and pneumonia,24392,1059,1.67 [1.41-1.99],3.316119553335834e-09
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,24359,566,1.65 [1.32-2.05],7.434235183584569e-06
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Other diseases of pleura,24390,1116,1.60 [1.37-1.87],4.291045884628903e-09
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Other pleural conditions,23307,33,3.01 [1.98-4.58],2.2966433377881625e-07
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,24500,181,2.31 [1.68-3.18],2.680748351675603e-07
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Pleural effusion,23810,536,1.93 [1.58-2.35],1.0565891273983164e-10
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",24204,871,1.68 [1.39-2.03],6.608082081864296e-08
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Pulmonary oedema,24355,36,4.13 [2.94-5.80],2.9464412502976825e-16
CLSTN3,Calsyntenin-3,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,24339,546,1.69 [1.36-2.10],2.53211865459758e-06
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Alcoholic liver disease,23868,77,2.40 [1.69-3.40],9.354978961498576e-07
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC)",23015,49,3.06 [2.02-4.62],1.1543308998418189e-07
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Cholangitis (primary sclerosing, PSC), with reimbursement 202",24191,49,3.07 [2.03-4.66],1.233048846851374e-07
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Cirrhosis of liver, NAS",24424,75,3.56 [2.64-4.80],6.917860327449385e-17
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Diseases of liver,24446,655,1.94 [1.62-2.32],4.724782564109046e-13
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Fibrosis and cirrhosis of liver,23884,93,3.28 [2.48-4.34],8.889338050769241e-17
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,"Hepatic failure, not elsewhere classified",23836,45,2.91 [1.86-4.53],2.490553091276429e-06
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Nonalcoholic fatty liver disease,24529,340,1.94 [1.51-2.49],2.761527657400661e-07
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other diseases of liver,24318,527,1.96 [1.61-2.40],5.4084395293929615e-11
CLSTN3,Calsyntenin-3,Chapter XI Diseases of the digestive system,Other inflammatory liver diseases,23863,72,2.76 [1.87-4.08],3.769887199499602e-07
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,24227,191,2.16 [1.60-2.91],4.148868206433962e-07
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sicca syndrome [SjÂšgren],24115,79,2.50 [1.75-3.58],5.233798395740611e-07
CLSTN3,Calsyntenin-3,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,24181,145,2.34 [1.80-3.05],2.546214960854888e-10
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Acute renal failure,24089,753,1.91 [1.59-2.28],1.8594992404758104e-12
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,23902,566,1.82 [1.46-2.27],7.699560829991404e-08
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Glomerular disorders in diseases classified elsewhere,24431,59,2.74 [1.80-4.19],3.0294488005632898e-06
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,24392,1333,1.74 [1.51-2.01],3.2700538363000947e-14
CLSTN3,Calsyntenin-3,Chapter XIV Diseases of the genitourinary system,"Tubulo-interstitial nephritis, not specified as acute or chronic",23184,125,2.21 [1.59-3.06],2.0445688683252988e-06
